[HTML][HTML] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
[引用][C] OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL …
Background: Follicular lymphoma (FL) patients may receive many lines of treatment (LoTs)
to maintain disease control. Current clinical outcomes in later LoTs (≥ 3 rd) are not well …
to maintain disease control. Current clinical outcomes in later LoTs (≥ 3 rd) are not well …
[HTML][HTML] A retrospective cohort study of treatment outcomes of adult patients with relapsed or refractory follicular lymphoma (ReCORD-FL)
G Salles, SJ Schuster, L Fischer, J Kuruvilla… - …, 2022 - journals.lww.com
This study (ReCORD-FL) sought to construct a historical control cohort to augment single-
arm trials in relapsed/refractory follicular lymphoma (r/r FL). A retrospective study in 10 …
arm trials in relapsed/refractory follicular lymphoma (r/r FL). A retrospective study in 10 …
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a …
C Casulo, MC Larson, JJ Lunde… - The Lancet …, 2022 - thelancet.com
Background Novel therapies for relapsed or refractory follicular lymphoma are commonly
evaluated in single-arm studies without formal comparison with other treatments or historical …
evaluated in single-arm studies without formal comparison with other treatments or historical …
[HTML][HTML] Treatment patterns and survival outcomes in patients with follicular lymphoma: a 2007 to 2015 Humedica database study
VA Morrison, Y Shou, JA Bell, L Hamilton… - … Myeloma and Leukemia, 2019 - Elsevier
Background Few studies have evaluated real-world treatment patterns and survival in
follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed …
follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed …
[HTML][HTML] Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study
BK Link, B Day, X Zhou, AD Zelenetz… - British journal of …, 2019 - Wiley Online Library
Follicular lymphoma (FL) is the second most common lymphoma, and by virtue of its
chronicity, may be the most prevalent and most treated lymphoma in the United States …
chronicity, may be the most prevalent and most treated lymphoma in the United States …
[HTML][HTML] Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups
Patients with follicular lymphoma (FL) frequently require multiple treatments during their
disease course; however, survival based on lines of treatment remains poorly described in …
disease course; however, survival based on lines of treatment remains poorly described in …
[HTML][HTML] Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience
Although the introduction of immunotherapy has improved outcomes for follicular lymphoma
(FL) patients, histological transformation (HT) and early relapse still confer a poor prognosis …
(FL) patients, histological transformation (HT) and early relapse still confer a poor prognosis …
Long-term results of the FOLL05 trial comparing R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular …
S Luminari, A Ferrari, M Manni, A Dondi… - Journal of Clinical …, 2018 - iris.unimore.it
Purpose The FOLL05 trial compared R-CVP (rituximab plus cyclophosphamide, vincristine,
and prednisone) with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine …
and prednisone) with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine …
相关搜索
- treatment patterns and outcomes
- relapsed or refractory follicular lymphoma
- patients with follicular lymphoma
- treatment response follicular lymphoma
- patterns of change follicular lymphoma
- later lines follicular lymphoma
- therapy in follicular lymphoma
- prolonged survival follicular lymphoma
- prior lines follicular lymphoma
- follicular lymphoma in the united states
- gitmo iil follicular lymphoma
- rituximab era follicular lymphoma
- chemo immunotherapy follicular lymphoma
- disease recurrence follicular lymphoma
- modern era follicular lymphoma
- meta analysis follicular lymphoma